![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RSL1D1 |
Gene summary for RSL1D1 |
![]() |
Gene information | Species | Human | Gene symbol | RSL1D1 | Gene ID | 26156 |
Gene name | ribosomal L1 domain containing 1 | |
Gene Alias | CSIG | |
Cytomap | 16p13.13 | |
Gene Type | protein-coding | GO ID | GO:0000470 | UniProtAcc | O76021 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
26156 | RSL1D1 | GSM4909285 | Human | Breast | IDC | 3.11e-06 | -2.03e-01 | 0.21 |
26156 | RSL1D1 | GSM4909286 | Human | Breast | IDC | 1.28e-11 | -2.65e-01 | 0.1081 |
26156 | RSL1D1 | GSM4909293 | Human | Breast | IDC | 9.07e-09 | -2.78e-01 | 0.1581 |
26156 | RSL1D1 | GSM4909294 | Human | Breast | IDC | 1.56e-20 | -4.93e-01 | 0.2022 |
26156 | RSL1D1 | GSM4909296 | Human | Breast | IDC | 1.92e-25 | -5.06e-01 | 0.1524 |
26156 | RSL1D1 | GSM4909297 | Human | Breast | IDC | 1.33e-32 | -5.13e-01 | 0.1517 |
26156 | RSL1D1 | GSM4909299 | Human | Breast | IDC | 7.67e-05 | -2.55e-01 | 0.035 |
26156 | RSL1D1 | GSM4909301 | Human | Breast | IDC | 3.71e-24 | -5.72e-01 | 0.1577 |
26156 | RSL1D1 | GSM4909302 | Human | Breast | IDC | 9.22e-05 | -3.79e-01 | 0.1545 |
26156 | RSL1D1 | GSM4909304 | Human | Breast | IDC | 6.06e-07 | -2.59e-01 | 0.1636 |
26156 | RSL1D1 | GSM4909307 | Human | Breast | IDC | 2.69e-02 | -2.17e-01 | 0.1569 |
26156 | RSL1D1 | GSM4909309 | Human | Breast | IDC | 1.68e-05 | -4.04e-01 | 0.0483 |
26156 | RSL1D1 | GSM4909311 | Human | Breast | IDC | 1.32e-52 | -5.57e-01 | 0.1534 |
26156 | RSL1D1 | GSM4909312 | Human | Breast | IDC | 5.62e-16 | -2.66e-01 | 0.1552 |
26156 | RSL1D1 | GSM4909313 | Human | Breast | IDC | 3.85e-04 | -1.62e-01 | 0.0391 |
26156 | RSL1D1 | GSM4909315 | Human | Breast | IDC | 3.65e-13 | -3.92e-01 | 0.21 |
26156 | RSL1D1 | GSM4909316 | Human | Breast | IDC | 1.46e-05 | -5.10e-01 | 0.21 |
26156 | RSL1D1 | GSM4909319 | Human | Breast | IDC | 2.39e-69 | -5.95e-01 | 0.1563 |
26156 | RSL1D1 | GSM4909320 | Human | Breast | IDC | 8.34e-08 | -4.73e-01 | 0.1575 |
26156 | RSL1D1 | GSM4909321 | Human | Breast | IDC | 1.05e-32 | -5.08e-01 | 0.1559 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004227316 | Endometrium | AEH | ribosomal large subunit biogenesis | 30/2100 | 72/18723 | 3.69e-11 | 5.03e-09 | 30 |
GO:004225416 | Endometrium | AEH | ribosome biogenesis | 67/2100 | 299/18723 | 1.95e-08 | 1.18e-06 | 67 |
GO:00016498 | Endometrium | AEH | osteoblast differentiation | 52/2100 | 229/18723 | 4.74e-07 | 1.92e-05 | 52 |
GO:00015038 | Endometrium | AEH | ossification | 78/2100 | 408/18723 | 1.54e-06 | 4.85e-05 | 78 |
GO:00063648 | Endometrium | AEH | rRNA processing | 47/2100 | 225/18723 | 1.78e-05 | 3.65e-04 | 47 |
GO:00004704 | Endometrium | AEH | maturation of LSU-rRNA | 12/2100 | 28/18723 | 2.08e-05 | 4.13e-04 | 12 |
GO:00160728 | Endometrium | AEH | rRNA metabolic process | 48/2100 | 236/18723 | 3.01e-05 | 5.54e-04 | 48 |
GO:000756810 | Endometrium | AEH | aging | 59/2100 | 339/18723 | 4.00e-04 | 4.28e-03 | 59 |
GO:00344707 | Endometrium | AEH | ncRNA processing | 62/2100 | 395/18723 | 3.93e-03 | 2.65e-02 | 62 |
GO:002261317 | Endometrium | EEC | ribonucleoprotein complex biogenesis | 108/2168 | 463/18723 | 4.60e-13 | 9.86e-11 | 108 |
GO:004227317 | Endometrium | EEC | ribosomal large subunit biogenesis | 30/2168 | 72/18723 | 8.19e-11 | 1.07e-08 | 30 |
GO:004225417 | Endometrium | EEC | ribosome biogenesis | 68/2168 | 299/18723 | 2.90e-08 | 1.68e-06 | 68 |
GO:000164914 | Endometrium | EEC | osteoblast differentiation | 53/2168 | 229/18723 | 5.32e-07 | 2.02e-05 | 53 |
GO:000150313 | Endometrium | EEC | ossification | 79/2168 | 408/18723 | 2.72e-06 | 7.67e-05 | 79 |
GO:000756815 | Endometrium | EEC | aging | 66/2168 | 339/18723 | 1.46e-05 | 2.87e-04 | 66 |
GO:000636416 | Endometrium | EEC | rRNA processing | 48/2168 | 225/18723 | 1.88e-05 | 3.50e-04 | 48 |
GO:000047013 | Endometrium | EEC | maturation of LSU-rRNA | 12/2168 | 28/18723 | 2.88e-05 | 5.03e-04 | 12 |
GO:001607216 | Endometrium | EEC | rRNA metabolic process | 49/2168 | 236/18723 | 3.27e-05 | 5.62e-04 | 49 |
GO:00075696 | Endometrium | EEC | cell aging | 28/2168 | 132/18723 | 1.05e-03 | 9.17e-03 | 28 |
GO:003447012 | Endometrium | EEC | ncRNA processing | 63/2168 | 395/18723 | 5.20e-03 | 3.26e-02 | 63 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RSL1D1 | SNV | Missense_Mutation | novel | c.806N>C | p.Ser269Thr | p.S269T | O76021 | protein_coding | tolerated(0.19) | benign(0.104) | TCGA-AC-A2FM-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
RSL1D1 | SNV | Missense_Mutation | novel | c.1406C>A | p.Ser469Tyr | p.S469Y | O76021 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RSL1D1 | SNV | Missense_Mutation | c.670N>A | p.Glu224Lys | p.E224K | O76021 | protein_coding | tolerated(0.11) | benign(0.206) | TCGA-AR-A251-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
RSL1D1 | SNV | Missense_Mutation | c.617N>T | p.Ser206Phe | p.S206F | O76021 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-B6-A0IB-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD | |
RSL1D1 | SNV | Missense_Mutation | rs780843348 | c.427N>A | p.Glu143Lys | p.E143K | O76021 | protein_coding | deleterious(0) | probably_damaging(0.974) | TCGA-D8-A1XL-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine+cyclophosphamide+tamoxifen | SD |
RSL1D1 | insertion | Frame_Shift_Ins | novel | c.1350_1351insCCCAGCACTTTGGAAC | p.Ala451ProfsTer22 | p.A451Pfs*22 | O76021 | protein_coding | TCGA-A2-A0CT-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cytoxan | SD | ||
RSL1D1 | insertion | Nonsense_Mutation | novel | c.1307_1308insCCCTTGACCCTGGACATATTCCAAGACTCTTTTACATTATGT | p.Glu436delinsAspProTerProTrpThrTyrSerLysThrLeuLeuHisTyrVal | p.E436delinsDP*PWTYSKTLLHYV | O76021 | protein_coding | TCGA-AO-A03R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | ||
RSL1D1 | insertion | Frame_Shift_Ins | novel | c.1187_1188insCAAAACTGAAAAAAAGAGAAAAAAAAAAACATCTAGCTCT | p.Pro397LysfsTer15 | p.P397Kfs*15 | O76021 | protein_coding | TCGA-AR-A0TY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | PD | ||
RSL1D1 | deletion | Frame_Shift_Del | c.964delG | p.Ala322HisfsTer9 | p.A322Hfs*9 | O76021 | protein_coding | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD | |||
RSL1D1 | deletion | Frame_Shift_Del | novel | c.191delT | p.Leu64TyrfsTer3 | p.L64Yfs*3 | O76021 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |